Gene · 57794
Papers4,188
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,321 to 1,340 of 4,188
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| HDLBP binds ER-targeted mRNAs by multivalent interactions to promote protein synthesis of transmembrane and secreted proteins. | Nat Commun | 2022 | 35585045 | PubTator, text mining | PubMed |
| RNA binding protein POP7 regulates ILF3 mRNA stability and expression to promote breast cancer progression. | Cancer Sci | 2022 | 35579257 | PubTator, text mining | PubMed |
| The Interplay Between Autophagy and RNA Homeostasis: Implications for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. | Front Cell Dev Biol | 2022 | 35573690 | PubTator, text mining | PubMed |
| Survival Prognosis, Tumor Immune Landscape, and Immune Responses of ADAMTS14 in Clear Cell Renal Cell Carcinoma and Its Potential Mechanisms. | Front Immunol | 2022 | 35572505 | PubTator, text mining | PubMed |
| The value of WNT5A as prognostic and immunological biomarker in pan-cancer. | Ann Transl Med | 2022 | 35571400 | PubTator, text mining | PubMed |
| Circulating Noncoding RNAs in Pituitary Neuroendocrine Tumors-Two Sides of the Same Coin. | Int J Mol Sci | 2022 | 35563510 | PubTator, text mining | PubMed |
| HPV16 and HPV18 Genome Structure, Expression, and Post-Transcriptional Regulation. | Int J Mol Sci | 2022 | 35563334 | PubTator, text mining | PubMed |
| Integrated analyses of an RNA binding protein-based signature related to tumor immune microenvironment and candidate drugs in osteosarcoma. | Am J Transl Res | 2022 | 35559393 | PubTator, text mining | PubMed |
| Patient and clinician nudges to improve symptom management in advanced cancer using patient-generated health data: study protocol for the PROStep randomised controlled trial. | BMJ Open | 2022 | 35551088 | PubTator, text mining | PubMed |
| Sustained correction of hippocampal neurogenic and cognitive deficits after a brief treatment by Nutlin-3 in a mouse model of fragile X syndrome. | BMC Med | 2022 | 35549943 | PubTator, text mining | PubMed |
| Definition of germ layer cell lineage alternative splicing programs reveals a critical role for Quaking in specifying cardiac cell fate. | Nucleic Acids Res | 2022 | 35544276 | PubTator, text mining | PubMed |
| Whole Transcriptome Sequencing Identified CircRNA Profiles and the Related Networks in Schizophrenia. | J Mol Neurosci | 2022 | 35543802 | PubTator, text mining | PubMed |
| Are ATXN2 variants modifying our understanding about neural pathogenesis, phenotypes, and diagnostic? | Neural Regen Res | 2022 | 35535893 | PubTator, text mining | PubMed |
| 3'untranslated regions of tumor suppressor genes evolved specific features to favor cancer resistance. | Oncogene | 2022 | 35523946 | PubTator, text mining | PubMed |
| RNA-Binding Protein COL14A1, TNS1, NUSAP1 and YWHAE Are Valid Biomarkers to Predict Peritoneal Metastasis in Gastric Cancer. | Front Oncol | 2022 | 35515139 | PubTator, text mining | PubMed |
| Echocardiographic characteristics of patients with antisynthetase syndrome. | Pulm Circ | 2022 | 35514779 | PubTator, text mining | PubMed |
| In silico study predicts a key role of RNA-binding domains 3 and 4 in nucleolin-miRNA interactions. | Proteins | 2022 | 35514080 | PubTator, text mining | PubMed |
| Construction and validation of a prognostic model of RNA binding proteins in clear cell renal carcinoma. | BMC Nephrol | 2022 | 35513791 | PubTator, text mining | PubMed |
| RNA-binding protein MEX3D promotes cervical carcinoma tumorigenesis by destabilizing TSC22D1 mRNA. | Cell Death Discov | 2022 | 35513372 | PubTator, text mining | PubMed |
| Dynamic and widespread control of poly(A) tail length during macrophage activation. | RNA | 2022 | 35512831 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57794/papers?page=67